Europe: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Europe

The Europe prophylactic medicaments containing insulin market fell slightly to $X in 2022, remaining relatively unchanged against the previous year. The market value increased at an average annual rate of +2.1% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The level of consumption peaked at $X in 2014; however, from 2015 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Europe

In value terms, prophylactic medicaments containing insulin production fell slightly to $X in 2022 estimated in export price. The total output value increased at an average annual rate of +1.4% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2013 when the production volume increased by 31%. Over the period under review, production attained the peak level at $X in 2014; however, from 2015 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Europe

For the eighth year in a row, Europe recorded growth in overseas shipments of medicaments containing insulin but not antibiotics in measured doses, which increased by 4.2% to X tons in 2022. Total exports indicated strong growth from 2012 to 2022: its volume increased at an average annual rate of +6.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by +90.1% against 2012 indices. The most prominent rate of growth was recorded in 2013 when exports increased by 21% against the previous year. The volume of export peaked in 2022 and is expected to retain growth in the near future.

In value terms, prophylactic medicaments containing insulin exports declined to $X in 2022. In general, exports, however, continue to indicate a slight decline. The most prominent rate of growth was recorded in 2013 when exports increased by 30%. Over the period under review, the exports hit record highs at $X in 2014; however, from 2015 to 2022, the exports remained at a lower figure.

Exports by Country

In 2022, France (X tons) was the key exporter of medicaments containing insulin but not antibiotics in measured doses, making up 65% of total exports. Italy (X tons) took the second position in the ranking, followed by Germany (X tons). All these countries together held near 25% share of total exports. Hungary (X tons) followed a long way behind the leaders.

From 2012 to 2022, average annual rates of growth with regard to prophylactic medicaments containing insulin exports from France stood at +7.2%. At the same time, Italy (+10.1%) and Hungary (+4.2%) displayed positive paces of growth. Moreover, Italy emerged as the fastest-growing exporter exported in Europe, with a CAGR of +10.1% from 2012-2022. Germany experienced a relatively flat trend pattern. Italy (+3.6 p.p.) and France (+3.3 p.p.) significantly strengthened its position in terms of the total exports, while Germany saw its share reduced by -8.4% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest prophylactic medicaments containing insulin supplying countries in Europe were Germany ($X), France ($X) and Italy ($X), together accounting for 92% of total exports.

Italy, with a CAGR of +8.2%, recorded the highest growth rate of the value of exports, among the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the export price in Europe amounted to $X per ton, reducing by -14.2% against the previous year. Overall, the export price recorded a abrupt shrinkage. The pace of growth appeared the most rapid in 2014 an increase of 13% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2015 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Germany ($X per ton), while France ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Hungary (+0.0%), while the other leaders experienced a decline in the export price figures.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Europe

In 2022, purchases abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -12.6% to X tons, falling for the second year in a row after five years of growth. The total import volume increased at an average annual rate of +1.2% over the period from 2012 to 2022; the trend pattern remained consistent, with only minor fluctuations in certain years. The most prominent rate of growth was recorded in 2013 with an increase of 9.4%. The volume of import peaked at X tons in 2020; however, from 2021 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports declined remarkably to $X in 2022. Over the period under review, imports showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2020 with an increase of 28%. As a result, imports attained the peak of $X. From 2021 to 2022, the growth of imports failed to regain momentum.

Imports by Country

In 2022, France (X tons) and Germany (X tons) were the main importers of medicaments containing insulin but not antibiotics in measured doses in Europe, together making up 36% of total imports. Hungary (X tons) ranks next in terms of the total imports with a 6.4% share, followed by Spain (6.2%) and Italy (6.2%). The following importers - Belgium (X tons), the Netherlands (X tons), the UK (X tons), Greece (X tons), Romania (X tons), Russia (X tons), the Czech Republic (X tons) and Slovenia (X tons) - together made up 30% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the leading importing countries, was attained by Slovenia (with a CAGR of +18.1%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin importing markets in Europe were France ($X), Germany ($X) and Belgium ($X), together comprising 52% of total imports. The Netherlands, Hungary, Italy, the UK, Romania, the Czech Republic, Spain, Greece, Russia and Slovenia lagged somewhat behind, together accounting for a further 34%.

Slovenia, with a CAGR of +14.4%, recorded the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in Europe amounted to $X per ton, waning by -18.5% against the previous year. Overall, the import price saw a mild downturn. The most prominent rate of growth was recorded in 2020 when the import price increased by 25% against the previous year. As a result, import price reached the peak level of $X per ton. From 2021 to 2022, the import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was France ($X per ton), while Spain ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (+3.9%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform